Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / articles / LPSN - LIVEPERSON INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50000 In LivePerson To Contact Him Directly To Discuss Their Options | Benzinga


LPSN - LIVEPERSON INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50000 In LivePerson To Contact Him Directly To Discuss Their Options | Benzinga

  • If you suffered losses exceeding $50,000 investing in LivePerson stock or options between May 10, 2022 and March 16, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/LPSN.

    There is no cost or obligation to you.


    NEW YORK, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against LivePerson, Inc. ("LivePerson" or the "Company") (NASDAQ:LPSN) and reminds investors of the January 30, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

    Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California and Georgia.

    As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) the Company's disclosure controls and procedures contained a material weakness; (2) accordingly, LivePerson maintained deficient internal controls over its financial reporting; (3) as a result, LivePerson's Q3 2022 financial statements failed to disclose the suspension of WildHealth's Medicare reimbursements in connection with ...

    Full story available on Benzinga.com

  • Stock Information

    Company Name: LivePerson Inc.
    Stock Symbol: LPSN
    Market: NASDAQ
    Website: liveperson.com

    Menu

    LPSN LPSN Quote LPSN Short LPSN News LPSN Articles LPSN Message Board
    Get LPSN Alerts

    News, Short Squeeze, Breakout and More Instantly...